BCAL Diagnostics Publishes Governance Statement

BCAL Diagnostics Limited (AU:BDX) has released an update.

BCAL Diagnostics Limited has announced that their Corporate Governance Statement for the financial year ending June 30, 2024, is now available on their website. This statement, which details the company’s adherence to ASX Corporate Governance Council recommendations, has been approved by the board as of August 30, 2024. Investors can access the document directly via the provided URL to understand the company’s governance practices and principles.

For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.